Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 554

Results For "ENT"

9437 News Found

Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
News | December 03, 2023

Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma

The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene


INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application
Sustainability | December 03, 2023

INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application

The new ECO grade is made using renewable feedstock


Tele-MANAS Cell established at Armed Forces Medical College, Pune
News | December 02, 2023

Tele-MANAS Cell established at Armed Forces Medical College, Pune

This cell will serve as an extension of the Tele Mental Health Assistance and Networking Across States initiative of the Ministry of Health and Family welfare


AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access
People | December 02, 2023

AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access

Currently, Venkat is Lead – Market Access, India at Pfizer


Venus Remedies granted market authorizations in Saudi Arabia and Philippines
News | December 02, 2023

Venus Remedies granted market authorizations in Saudi Arabia and Philippines

These regulatory approvals signify a significant milestone for Venus Remedies Limited


Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US
Drug Approval | December 02, 2023

Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US

Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US


Biocon Biologics completes Integration of Viatris' Biosimilar business
News | December 01, 2023

Biocon Biologics completes Integration of Viatris' Biosimilar business

The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone


Eugia Pharma receives USFDA approval for Budesonide Inhalation Suspension
Drug Approval | December 01, 2023

Eugia Pharma receives USFDA approval for Budesonide Inhalation Suspension

The product is expected to be launched in FY25


Cipla partners with TEACH to create career opportunities for hearing-impaired youth
News | December 01, 2023

Cipla partners with TEACH to create career opportunities for hearing-impaired youth

The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals


New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence
News | December 01, 2023

New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence

A new GSK survey shows a large number of adults do not understand how shingles may be triggered